EUVIMEDEUVIMED entdecken
Crossref

Impact of Tissue Lipocalin-2 Expression on Pathologic Response and Prognosis Following Neoadjuvant Chemotherapy in Locally Advanced Triple-Negative Breast Cancer

Mehmet Emin Yılmaz, Öztürk Ateş, Berkan Karabuğa, Ergin Aydemir, Osman Bilge Kaya, Sedef Tatar Bolat, Mustafa Büyükkör, Diğdem Kurukafa, Olcay Kandemir

Eurasian Journal of Medical Advances · 2026 · 66-74

DOI: 10.14744/ejma.260666 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Eurasian Journal of Medical Advances, 2026. Verfasst von Mehmet Emin Yılmaz und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Yılmaz, M. E., Ateş, Ö., Karabuğa, B., Aydemir, E., Kaya, O. B., Bolat, S. T., Büyükkör, M., Kurukafa, D., & Kandemir, O. (2026). Impact of Tissue Lipocalin-2 Expression on Pathologic Response and Prognosis Following Neoadjuvant Chemotherapy in Locally Advanced Triple-Negative Breast Cancer. Eurasian Journal of Medical Advances, 66-74. https://doi.org/10.14744/ejma.260666

Vancouver

Yılmaz ME, Ateş Ö, Karabuğa B, Aydemir E, Kaya OB, Bolat ST, et al. Impact of Tissue Lipocalin-2 Expression on Pathologic Response and Prognosis Following Neoadjuvant Chemotherapy in Locally Advanced Triple-Negative Breast Cancer. Eurasian Journal of Medical Advances. 2026:66-74. doi:10.14744/ejma.260666

BibTeX
@article{Ylmaz2026,
  author = {Yılmaz, Mehmet Emin and Ateş, Öztürk and Karabuğa, Berkan and Aydemir, Ergin and Kaya, Osman Bilge and Bolat, Sedef Tatar and Büyükkör, Mustafa and Kurukafa, Diğdem and Kandemir, Olcay},
  title = {Impact of Tissue Lipocalin-2 Expression on Pathologic Response and Prognosis Following Neoadjuvant Chemotherapy in Locally Advanced Triple-Negative Breast Cancer},
  journal = {Eurasian Journal of Medical Advances},
  year = {2026},
  pages = {66--74},
  doi = {10.14744/ejma.260666}
}
Kostenlos starten →